Recent Quotes (30 days)

You have no recent quotes
chg | %

Innoviva Inc news

   Watch this stock
Showing stories 1 - 10 of about 90   

Articles published

INVA 13.78 +0.29 (2.15%)
price chart
Innoviva to Participate in Cantor Fitzgerald's Global Healthcare Conference on ...
BRISBANE, Calif.--(BUSINESS WIRE)--Innoviva, Inc. (NASDAQ: INVA) today announced that Michael W. Aguiar, Innoviva's President and Chief Executive Officer and Eric d'Esparbes, SVP and Chief Financial Officer will present at the Cantor Fitzgerald Global ...
GSK and Innoviva Report Positive Headline Results from IMPACT Study Showing ...
LONDON--(BUSINESS WIRE)--GlaxoSmithKline plc (LSE/NYSE: GSK) and Innoviva, Inc. (NASDAQ: INVA) today announced positive headline results from the landmark phase III IMPACT study of Trelegy Ellipta, the first and only FDA approved once-daily ...
Glaxo-Innoviva's Triple Combo Inhaler Positive in Phase III  Nasdaq
Theravance Biopharma Highlights Positive Headline Results from IMPACT Study ...  Markets Insider
State of Wisconsin Investment Board Buys New Position in Innoviva, Inc. (INVA)
Innoviva logo State of Wisconsin Investment Board bought a new stake in Innoviva, Inc. (NASDAQ:INVA) during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission.
Innoviva, Inc. (NASDAQ:INVA) Runs -0.65% For the Week  Concord Register
Old Mutual Global Investors UK Ltd. Reduces Holdings in Innoviva, Inc ...  Dispatch Tribunal
Innoviva to Participate in Baird Global Healthcare Conference on September 7
BUSINESS WIRE)--Innoviva, Inc. (NASDAQ: INVA) today announced that Michael W. Aguiar, Innoviva's President and Chief Executive Officer and Eric d'Esparbes, the Company's Senior Vice President and Chief Financial Officer will participate in the 2017 ...
Theravance Biopharma (TBPH) Highlights GlaxoSmithKline and Innoviva's Receipt ...
Theravance Biopharma, Inc. (NASDAQ: TBPH) ("Theravance Biopharma") today highlighted that GlaxoSmithKline plc (GSK) and Innoviva, Inc. (Innoviva) have received a positive opinion from the European Medicines Agency's (EMA) Committee for Medicinal ...
Glaxo's Triple Therapy COPD Inhaler Gets CHMP Nod in the EU  Nasdaq
Once-Daily COPD Inhaler Therapy Receives Positive Indication in Europe  Pharmaceutical Processing
Study from GlaxoSmithKline and Innoviva Inc. improves asthma control
GlaxoSmithKline plc and Innoviva recently conducted a first of its kind research on asthma control. The Salford Lung Study (SLS) results revealed patients initiated with Relvar Ellipta, a once a day inhaler, had twice the odds of achieving an ...
GSK, Innoviva: Trelegy Ellipta Gets CHMP Positive Opinion In Europe For COPD
(RTTNews.com) - GlaxoSmithKline Plc (GSK.L, GSK) and Innoviva, Inc. (INVA) announced Friday that Trelegy Ellipta once-daily single inhaler triple therapy received positive opinion from the European Medicines Agency'sCommittee for Medicinal Products for ...
Innoviva (INVA) & GlaxoSmithKline Plc (GSK) Reports Positive Opinion ...  StreetInsider.com
Should You Buy Innoviva, Inc. (INVA) or Intuit Inc. (INTU)?
Innoviva, Inc. (NASDAQ:INVA) and Intuit Inc. (NASDAQ:INTU) are both Technology companies that recently hit new low. Naturally, this has created a bit of a stir amongst investors.
Analysts Take Aim at Innoviva, Inc. (NASDAQ:INVA) Shares
Innoviva, Inc. (NASDAQ:INVA) currently has an A verage Broker Rating of 3.06. This number is based on the 5 sell-side firms polled by Zacks.
Breaking: Innoviva Inc (NASDAQ:INVA) Stock Through Resistance -- Technicals ...
Breaking: Innoviva Inc (NASDAQ:INVA) has hit maximum technical strength -- watch the technical oscillators for momentum gaps.
Innoviva, Inc. (NASDAQ:INVA) Rating Lowered to Hold at ValuEngine  The Ledger Gazette
Innoviva Inc (INVA) Stock Overview  ExpertGazette